185 related articles for article (PubMed ID: 38213901)
1. Comprehensive exploration of JQ1 and GSK2801 targets in breast cancer using network pharmacology and molecular modeling approaches.
Yellapu NK; Pei D; Nissen E; Thompson JA; Koestler DC
Comput Struct Biotechnol J; 2023; 21():3224-3233. PubMed ID: 38213901
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer.
Yellapu NK; Ly T; Sardiu ME; Pei D; Welch DR; Thompson JA; Koestler DC
BMC Cancer; 2022 Jun; 22(1):627. PubMed ID: 35672711
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental validation for deciphering the action mechanism of
Bhat BA; Rashid Mir W; Alkhanani M; Almilaibary A; Mir MA
J Biomol Struct Dyn; 2023 Nov; ():1-21. PubMed ID: 37948293
[No Abstract] [Full Text] [Related]
4. Uncovering the molecular mechanism of Gynostemma pentaphyllum (Thunb.) Makino against breast cancer using network pharmacology and molecular docking.
Wang WX; He XY; Yi DY; Tan XY; Wu LJ; Li N; Feng BB
Medicine (Baltimore); 2022 Dec; 101(49):e32165. PubMed ID: 36626523
[TBL] [Abstract][Full Text] [Related]
5. A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer.
Dong Y; Hao L; Fang K; Han XX; Yu H; Zhang JJ; Cai LJ; Fan T; Zhang WD; Pang K; Ma WM; Wang XT; Han CH
BMC Complement Med Ther; 2021 Jan; 21(1):45. PubMed ID: 33494738
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation.
Liang J; Cheng L; Feng J; Han Z; Huang C; Xie F; Li Y; Luo X; Wang Q; He J; Chen H
BMC Complement Med Ther; 2023 Oct; 23(1):361. PubMed ID: 37833759
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis.
Lv Y; Mou Y; Su J; Liu S; Ding X; Yuan Y; Li G; Li G
Sci Rep; 2023 Mar; 13(1):3816. PubMed ID: 36882618
[TBL] [Abstract][Full Text] [Related]
8. The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology.
Zheng L; Jiang H; Li R; Song L; Chen R; Dong H
Contrast Media Mol Imaging; 2022; 2022():3900636. PubMed ID: 35350700
[TBL] [Abstract][Full Text] [Related]
9. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
Zhu N; Huang B; Zhu L; Wang Y
J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and
Huang S; Chen Y; Pan L; Fei C; Wang N; Chu F; Peng D; Duan X; Wang Y
Front Oncol; 2021; 11():731522. PubMed ID: 34513708
[TBL] [Abstract][Full Text] [Related]
11. A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment.
Lee HS; Lee IH; Kang K; Park SI; Moon SJ; Lee CH; Lee DY
Evid Based Complement Alternat Med; 2021; 2021():3919143. PubMed ID: 33628298
[TBL] [Abstract][Full Text] [Related]
12. GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.
Bevill SM; Olivares-Quintero JF; Sciaky N; Golitz BT; Singh D; Beltran AS; Rashid NU; Stuhlmiller TJ; Hale A; Moorman NJ; Santos CM; Angus SP; Zawistowski JS; Johnson GL
Mol Cancer Res; 2019 Jul; 17(7):1503-1518. PubMed ID: 31000582
[TBL] [Abstract][Full Text] [Related]
13. [Antidepressant effect and molecular mechanism of notoginsenoside R_1 based on network pharmacology and animal experiments].
Li Y; Zhang YY; Wu D; Qi KM; Lu W; Wei YC
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5599-5609. PubMed ID: 36471978
[TBL] [Abstract][Full Text] [Related]
14. Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: Coupling network pharmacology with experimental validation.
Shi Y; Wu Y; Li F; Zhang Y; Hua C; Yang J; Zheng J; Chen L; Wei Z; Yue H; Sun C; Zhou X; Liu S
J Ethnopharmacol; 2022 Jul; 293():115326. PubMed ID: 35489659
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine.
Shen Z; Pu S; Cao X; Tang M; Wang S; Bai D; Jiang G
Epilepsy Res; 2023 Jan; 189():107066. PubMed ID: 36571905
[TBL] [Abstract][Full Text] [Related]
16. A network-based pharmacological study on the mechanism of action of muscone in breast cancer.
Zhao Y; Tao S; Wang Q; Liu Y; Yang W; Zhang S; Su Z; Ma X
Transl Cancer Res; 2022 May; 11(5):1195-1206. PubMed ID: 35706803
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation.
Tang L; Gao J; Li X; Cao X; Zhou B
Drug Des Devel Ther; 2022; 16():4205-4221. PubMed ID: 36530790
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
[TBL] [Abstract][Full Text] [Related]
20. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
